Global Autoinjectors Market Is Anticipated To Grow At a 17.4% CAGR During 2021-2027, Abbvie, Ypsomed, Consort Medical, Johnson & Johnson, Mylan


Posted March 21, 2022 by vynzresearch2reportindustry

VynZ Research is a global market intelligence company providing research reports.

 
The global autoinjectors market is anticipated to grow at a 17.4% CAGR during 2021-2027 and will reach USD 5.5 billion by 2027. Factors attributing to the growth of the autoinjector market include rising prevalence of anaphylaxis, diabetes, and rheumatoid arthritis, increased prominence of targeted therapies, mounting preference of self-administration of drugs, ease in availability of a generic version of autoinjectors, rising number of regulatory approvals, initiatives by government and favorable reimbursement policies, technological development and rising preference of painless injection will accelerate the growth of the autoinjectors market. Furthermore, the growing elderly population increased demand for home healthcare practices and offers several advantages like high accuracy, less risk of needlestick injuries, consistent delivery of dosage.

The COVID-19 outbreak has led to a decrease in patients requiring care and treatment along with a decline in clinical trial recruitment of new therapies, resulting in a negative impact on the global autoinjectors market in the first phase of the crisis. However, the market had a steady growth owing to rising demand for efficient home care and remote monitoring so as to handle chronic illness and allergies without visiting the hospital.

Download Free Sample Copy Of Research Report: https://www.vynzresearch.com/healthcare/autoinjectors-market/request-sample

Multiple sclerosis, anaphylaxis, rheumatoid arthritis, diabetes, and other therapeutic applications divide the global autoinjectors market. Rheumatoid arthritis dominates the market owing to the rising prevalence of rheumatoid arthritis.

The autoinjectors market is divided into two types: reusable and disposable autoinjectors. The disposable autoinjectors category held the greatest share of the worldwide autoinjectors market because of its ease of use and the existence of a built-in glass syringe, disposable autoinjectors are the most popular autoinjectors among patients with poor dexterity or visual impairments.

North America dominates the global autoinjector market owing to continuous technical breakthroughs in medical devices, a rising number of patients suffering from diabetes and anaphylaxis, and favorable government policies. Other factors likely to contribute to market expansion in the region include rising demand for home healthcare devices and a strong presence of major competitors.

In September 2021, the world's first autoinjector for prefilled syringes with integrated connection has been presented by Ypsomed. The YpsoMate On combines the benefits of the well-known YpsoMate autoinjector with digital therapeutic support possibilities. The YpsoMate On adheres to an eco-design approach that supports the use of sustainable components and enables easy recycling of electronic components.

The prominent players in the global autoinjector industry include Abbvie, Ypsomed, Consort Medical, Johnson & Johnson, Mylan, Becton, Dickinson and Company, Amgen, Haselmeier, ELI Lilly, Owen Mumford, Scandinavian Health Limited, and Antares Pharma.

Source: VynZ Research
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By VynZ Research
Phone 09599764363
Business Address Noida, India
Uttar Pradesh
Country India
Categories Business , Free , Industry
Tags autoinjectors , autoinjectors market , autoinjectors market analysis , autoinjectors market growth , autoinjectors market share , autoinjectors market size , autoinjectors market trend , autoinjectors market value
Last Updated March 21, 2022